$17.88 -0.07 (-0.38%)

Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM)

Quantum Biopharma Ltd. is a biotechnology company focused on developing and commercializing innovative therapies in the biopharmaceutical sector. The company aims to leverage advanced scientific research to create targeted treatments, particularly in areas such as neurodegenerative diseases and other unmet medical needs. Its Class B subordinate voting shares (QNTM) represent equity ownership and voting rights within the company, offering investors opportunities to participate in its growth and development efforts.

🚫 Quantum Biopharma Ltd. Class B Subordinate Voting Shares does not pay dividends

Company News

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case
GlobeNewswire Inc. • Zeeshan Saeed • October 3, 2025

Quantum BioPharma will distribute Contingent Value Rights (CVRs) on October 27, 2025, tied to potential litigation settlement proceeds against CIBC World Markets and RBC Dominion Securities, seeking over $700 million in damages.

Quantum BioPharma Shares Are Up Over 80%: What's Going On?
Benzinga • Vaishali Prayag • February 6, 2025

Quantum BioPharma shares surged over 80% after its licensee, Celly Nutrition, engaged a New York investment bank to raise $10 million and explore a potential U.S. initial public offering.